ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.704,42
-0,11%
S&P 500
5.303,27
0,12%
Dow Jones
40.003,59
0,34%
Euro vs US Dollar
1,08905
-0,04%
Bitcoin
67.122,19
0,27%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Reviva Pharmaceuticals Holdings Inc (RVPH)

  7. Reviva Pharmaceuticals Holdings Inc (RVPH) News

RVPH

Reviva Pharmaceuticals (RVPH)

Reviva Pharmaceuticals Holdings Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:RVPH
DatumZeitQuelleÜberschriftSymbolFirma
16/02/202422h32Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
14/02/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
13/02/202423h00Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
02/02/202422h38Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
17/11/202322h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
17/11/202322h03Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
14/11/202322h12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
30/10/202313h20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
04/10/202323h19Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
04/10/202323h03Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
04/10/202323h02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
17/08/202312h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
14/08/202322h16Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
14/08/202322h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
24/07/202322h16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
23/06/202312h31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
15/05/202322h32Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
15/05/202322h28Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
05/05/202322h31Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
27/04/202322h34Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
27/04/202322h34Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
27/04/202322h33Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
30/03/202314h12Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
30/03/202314h07Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
30/03/202313h52Edgar (US Regulatory)Annual Report (10-k)NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
30/03/202313h47Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
14/02/202322h03Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
04/01/202312h07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
21/11/202222h16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
16/11/202220h35TipRanksReviva Pharmaceuticals Holdings (RVPH) Receives a Buy from Maxim GroupNASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
 Showing the most relevant articles for your search:NASDAQ:RVPH

Kürzlich von Ihnen besucht

TSXV
ISM
COIN
GXTTBTC
Gem Exchange and Trading
EU
FRSG00014KJ1
SG Issuer Sg Issuer Fx M...
BIT
F12568
Vontobel Financial Produ...
COIN
MEDICUSD
NYSE
HOVU
BITMOT
982778
Aiib Tf 40% Ap25 Try
EU
FRSG00014D98
SG Issuer Mtn Mc Due 04/29
NASDAQ
GAAAX
GMO Opportunistic Income...
LSE
IMX
Ims Maxims
COIN
RENZECUSD
renZEC
USOTC
CGSHY
Country Garden Services (PK)
MRTX
GFCBTC
Globfone Coin
BOV
GDXB39M
VanEck Durable High Divi...
USOTC
CESSF
Chesser Resources (CE)
KUCN
SXPBTC
Swipe
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten